Stockreport

Cytokinetics up 4% premarket on FDA signoff on endpoint for pivotal study of reldesmetiv in SMA [Seeking Alpha]

Cytokinetics, Incorporated  (CYTK) 
Last cytokinetics, incorporated earnings: 3/3 04:00 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.cytokinetics.com/investor-overview
PDF Cytokinetics up 4% premarket on FDA signoff on endpoint for pivotal study of reldesmetiv in SMA [Read more]